(Q30311015)

English

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitors or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitors or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

author name string

Helmy M Siragy

1

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

publication date

1 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

Current Hypertension Reports

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

293-294

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

Nifedipine. Dose-related increase in mortality in patients with coronary heart disease

1 reference

https://api.crossref.org/works/10.1007%2FS11906-003-0036-7

21 January 2018

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12844462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12844462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://pubmed.ncbi.nlm.nih.gov/12844462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12844462

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11906-003-0036-7

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30311015&oldid=2194734015"